Today's Headlines - 16 August 2023
Rule to prescribe generic drugs
GS Paper - 3 (Health and Diseases)
After the National Medical Commission notified new guidelines on professional conduct recently, doctors have been protesting one of the stipulations — using generic names of medicines on the prescription instead of a particular brand name. The Indian Medical Association, the largest body of doctors in the country, said in a statement this was akin to “running trains without tracks.”
What do the guidelines say?
The guidelines say that doctors can only write the generic names of the medicine on the prescription.
For example, a doctor will have to prescribe paracetamol for fever, instead of Dolo or Calpol Every RMP should prescribe drugs using generic names written legibly, the guidelines say.
This practice can only be relaxed for medicines with narrow therapeutic index (drugs where a small difference in dosage may lead to adverse outcomes), biosimilars (a different version of biologic products that are manufactured in living systems), and “similar other exceptional cases.”
The guideline says that generic medicines, on average, are 30% to 80% cheaper than the branded versions, and are hence likely to bring down healthcare costs.
What does it mean for you?
The new guidelines do not allow doctors to write a specific brand, which means that you will get whichever medicine with the relevant active ingredient your pharmacist stocks.
If a pharmacy does not have a generic version of a medicine — which drug stores usually do not stock because of very low profit margins — the responsibility to substitute it with a branded medicine will shift to the pharmacist instead of the doctor. This will promote brands that have good profit margins, irrespective of how good they are.
Additionally, doctors say it will also take away their choice of prescribing the medicine they think is the best for a patient.
Taken in the context of the quality of generics varying across companies, this could result in ineffective treatment.
What are the issues with generic medicines?
Doctors, drug manufacturers, and the government all agree that there is much to be done when it comes to the quality of generic medicines in the country.
While the doctors in the IMA statement said that only 0.1% medicines are tested for quality checks, manufacturers said it is not possible for the government to test every batch, but following good manufacturing practices to the T can assure quality by design.
Many have also questioned the tests that a company needs to do to get approval. Until a few years ago, it was not mandatory for companies making generics to carry out bio-equivalence or stability studies.
Bioequivalence studies are done to show that the generic drug elicits the same response as a branded version.
Stability studies are done to see how the quality of the drug varies over a period under specific environmental conditions.
Experts from the pharmaceutical sector admit that there are drugs still in the market that never underwent these studies.
Data from the Union health ministry shows that around 3% of all medicines tested over the last three years — including generics, branded generics, and branded medicines — were found to be not of standard quality.
#upsc #news #headline #rule #prescribe #generic #drugs #health #diseases #national #medical #commission #medicines #indian #doctors #tracks #trains #indian #guidelines #paracetamol #RMP #Biosimilars #index #therapeutic #cases #healthcare #pharmacist #version
Rule to prescribe generic drugs
GS Paper - 3 (Health and Diseases)
After the National Medical Commission notified new guidelines on professional conduct recently, doctors have been protesting one of the stipulations — using generic names of medicines on the prescription instead of a particular brand name. The Indian Medical Association, the largest body of doctors in the country, said in a statement this was akin to “running trains without tracks.”
What do the guidelines say?
The guidelines say that doctors can only write the generic names of the medicine on the prescription.
For example, a doctor will have to prescribe paracetamol for fever, instead of Dolo or Calpol Every RMP should prescribe drugs using generic names written legibly, the guidelines say.
This practice can only be relaxed for medicines with narrow therapeutic index (drugs where a small difference in dosage may lead to adverse outcomes), biosimilars (a different version of biologic products that are manufactured in living systems), and “similar other exceptional cases.”
The guideline says that generic medicines, on average, are 30% to 80% cheaper than the branded versions, and are hence likely to bring down healthcare costs.
What does it mean for you?
The new guidelines do not allow doctors to write a specific brand, which means that you will get whichever medicine with the relevant active ingredient your pharmacist stocks.
If a pharmacy does not have a generic version of a medicine — which drug stores usually do not stock because of very low profit margins — the responsibility to substitute it with a branded medicine will shift to the pharmacist instead of the doctor. This will promote brands that have good profit margins, irrespective of how good they are.
Additionally, doctors say it will also take away their choice of prescribing the medicine they think is the best for a patient.
Taken in the context of the quality of generics varying across companies, this could result in ineffective treatment.
What are the issues with generic medicines?
Doctors, drug manufacturers, and the government all agree that there is much to be done when it comes to the quality of generic medicines in the country.
While the doctors in the IMA statement said that only 0.1% medicines are tested for quality checks, manufacturers said it is not possible for the government to test every batch, but following good manufacturing practices to the T can assure quality by design.
Many have also questioned the tests that a company needs to do to get approval. Until a few years ago, it was not mandatory for companies making generics to carry out bio-equivalence or stability studies.
Bioequivalence studies are done to show that the generic drug elicits the same response as a branded version.
Stability studies are done to see how the quality of the drug varies over a period under specific environmental conditions.
Experts from the pharmaceutical sector admit that there are drugs still in the market that never underwent these studies.
Data from the Union health ministry shows that around 3% of all medicines tested over the last three years — including generics, branded generics, and branded medicines — were found to be not of standard quality.
#upsc #news #headline #rule #prescribe #generic #drugs #health #diseases #national #medical #commission #medicines #indian #doctors #tracks #trains #indian #guidelines #paracetamol #RMP #Biosimilars #index #therapeutic #cases #healthcare #pharmacist #version
Today's Headlines - 19 August 2023
New non-poor emerging in India
GS Paper - 3 (Economy)
Prime Minister Narendra Modi said in his Independence Day address that in the first five-year term of his government, “13.5 crore of my fellow poor brothers and sisters have broken free from the chains of poverty and entered the new middle class”. The 13.5-crore number cited by the PM appears in the second National Multidimensional Poverty Index report that was published by Niti Aayog on 17 July 2023 (Some highlights in chart). The first such report was published in 2021.
What is the Multidimensional Poverty Index (MPI)?
The national MPI measures deprivations across the three dimensions of health and nutrition, education, and standard of living.
Within health, it tracks three variables: nutrition, child and adolescent mortality, and maternal health.
In education, it tracks two variables: years of schooling, and school attendance. And in standard of living, it tracks seven variables such as sanitation, drinking water, bank account, etc.
The index is based on the methodology used by the Oxford Poverty and Human Development Initiative (OPHI) and United Nations Development Programme (UNDP) to construct the Global MPI. OPHI and UNDP are technical partners in the formulation of the national index.
But India’s MPI is not exactly the same as the Global MPI. For instance, India’s MPI has 12 variables, while the Global MPI has 10. The two additional variables in India’s MPI are maternal health and bank account.
How does this reduce poverty?
It must be noted that this is a multidimensional poverty index and, as such, is not comparable to India’s traditional and official way of estimating poverty.
However, the Global MPI 2023 report, which too was released in July, states that 415 million people in India moved out of poverty between 2005-06 and 2019-21.
The Global MPI pegs India’s poverty ratio at 16.4% as against 14.96% in Niti Aayog’s MPI. This difference is on account of the two additional metrics, and some differences in definitions.
Does the reduction in poverty add to India’s middle class?
There is no official definition of the middle class in India. It is, therefore, difficult to say whether those who escape poverty necessarily join the middle class, or to what extent.
Estimates of India’s middle class provided by private research organisations peg the middle class at income levels that are considerably higher than those of the people who are coming out of poverty.
For instance, in a report, ‘The rise of India’s middle class’, published in July, People Research on India’s Consumer Economy (PRICE) divided all households into four categories: Destitutes, Aspirers, Middle Class and Rich. “…Households which are classified as Middle Class have an annual income in the range of Rs 5 lakh to Rs 30 lakh (at 2020-21 prices),” the report said. Destitute households were those with an annual income less than Rs 1.25 lakh.
According to PRICE’s survey, as of 2021, out of a population of 1,416 million, 196 million Indians were categorised as ‘Destitutes’, 432 million were the ‘Middle Class’, and 732 million were ‘Aspirers’.
#upsc #news #headline #nonpoor #emerging #india #economy #primeminister #Narendramodi #Independenceday #poverty #middle #nitiaayog #multidimensional #poverty #MPI #index #nutrition #education #bankaccount #OPHI #UNDP #methodology #oxford #sanitation #middle #class #india #research #consumer #destitude #population #price #survey #annualincome #middleclass #aspires #UNDP #technical #MPI
New non-poor emerging in India
GS Paper - 3 (Economy)
Prime Minister Narendra Modi said in his Independence Day address that in the first five-year term of his government, “13.5 crore of my fellow poor brothers and sisters have broken free from the chains of poverty and entered the new middle class”. The 13.5-crore number cited by the PM appears in the second National Multidimensional Poverty Index report that was published by Niti Aayog on 17 July 2023 (Some highlights in chart). The first such report was published in 2021.
What is the Multidimensional Poverty Index (MPI)?
The national MPI measures deprivations across the three dimensions of health and nutrition, education, and standard of living.
Within health, it tracks three variables: nutrition, child and adolescent mortality, and maternal health.
In education, it tracks two variables: years of schooling, and school attendance. And in standard of living, it tracks seven variables such as sanitation, drinking water, bank account, etc.
The index is based on the methodology used by the Oxford Poverty and Human Development Initiative (OPHI) and United Nations Development Programme (UNDP) to construct the Global MPI. OPHI and UNDP are technical partners in the formulation of the national index.
But India’s MPI is not exactly the same as the Global MPI. For instance, India’s MPI has 12 variables, while the Global MPI has 10. The two additional variables in India’s MPI are maternal health and bank account.
How does this reduce poverty?
It must be noted that this is a multidimensional poverty index and, as such, is not comparable to India’s traditional and official way of estimating poverty.
However, the Global MPI 2023 report, which too was released in July, states that 415 million people in India moved out of poverty between 2005-06 and 2019-21.
The Global MPI pegs India’s poverty ratio at 16.4% as against 14.96% in Niti Aayog’s MPI. This difference is on account of the two additional metrics, and some differences in definitions.
Does the reduction in poverty add to India’s middle class?
There is no official definition of the middle class in India. It is, therefore, difficult to say whether those who escape poverty necessarily join the middle class, or to what extent.
Estimates of India’s middle class provided by private research organisations peg the middle class at income levels that are considerably higher than those of the people who are coming out of poverty.
For instance, in a report, ‘The rise of India’s middle class’, published in July, People Research on India’s Consumer Economy (PRICE) divided all households into four categories: Destitutes, Aspirers, Middle Class and Rich. “…Households which are classified as Middle Class have an annual income in the range of Rs 5 lakh to Rs 30 lakh (at 2020-21 prices),” the report said. Destitute households were those with an annual income less than Rs 1.25 lakh.
According to PRICE’s survey, as of 2021, out of a population of 1,416 million, 196 million Indians were categorised as ‘Destitutes’, 432 million were the ‘Middle Class’, and 732 million were ‘Aspirers’.
#upsc #news #headline #nonpoor #emerging #india #economy #primeminister #Narendramodi #Independenceday #poverty #middle #nitiaayog #multidimensional #poverty #MPI #index #nutrition #education #bankaccount #OPHI #UNDP #methodology #oxford #sanitation #middle #class #india #research #consumer #destitude #population #price #survey #annualincome #middleclass #aspires #UNDP #technical #MPI
Today's Headlines - 04 September 2023
NITI Aayog, UNDP join hands to fast-track SDGs
GS Paper - 2 (Polity)
Central think tank NITI Aayog and the United Nations Development Programme (UNDP) signed a memorandum of understanding to formalise a cooperative framework to fast-track India's pursuit to achieve its sustainable development goals (SDGs), the Aayog said.
More about the memorandum of understanding
The memorandum of understanding will focus on the two organisations' cooperation on a range of areas, including SDG localisation, data-driven monitoring, Aspirational Districts and Blocks, among others.
Over the years, NITI Aayog and UNDP's collaboration has grown from strength to strength. This partnership would foster data-driven policy interventions and programmatic action.
NITI Aayog is the nodal body for the monitoring of SDGs in India and reviews the process through a nationwide SDG index. The memorandum of understanding between the think tank and UNDP was signed for a period of years.
Midway to 2030, India's leadership is critical for making the SDGs a reality. India nearly halved multidimensional poverty between 2015-2016 and 2019-2021, demonstrating that despite complex challenges, accelerating progress towards the Goals is possible.
Through this memorandum of understanding with NITI Aayog, UNDP will also provide support for NITI Aayog's work on women's livelihoods, innovation, and Mission LiFE.
#upsc #news #headline #NitiAayog #UNDP #fasttrack #SDGs #Polity #cooperative #framework #sustainable #goals #Aayog #memorandum #districts #blocks #localisation #monitoring #collaboration #data #leadership #periodofyears #complex #challenges #livelihoods #innovation #mission #life #data #driven #patnership #demonstrating #nationwidwe #index #multidimensional
NITI Aayog, UNDP join hands to fast-track SDGs
GS Paper - 2 (Polity)
Central think tank NITI Aayog and the United Nations Development Programme (UNDP) signed a memorandum of understanding to formalise a cooperative framework to fast-track India's pursuit to achieve its sustainable development goals (SDGs), the Aayog said.
More about the memorandum of understanding
The memorandum of understanding will focus on the two organisations' cooperation on a range of areas, including SDG localisation, data-driven monitoring, Aspirational Districts and Blocks, among others.
Over the years, NITI Aayog and UNDP's collaboration has grown from strength to strength. This partnership would foster data-driven policy interventions and programmatic action.
NITI Aayog is the nodal body for the monitoring of SDGs in India and reviews the process through a nationwide SDG index. The memorandum of understanding between the think tank and UNDP was signed for a period of years.
Midway to 2030, India's leadership is critical for making the SDGs a reality. India nearly halved multidimensional poverty between 2015-2016 and 2019-2021, demonstrating that despite complex challenges, accelerating progress towards the Goals is possible.
Through this memorandum of understanding with NITI Aayog, UNDP will also provide support for NITI Aayog's work on women's livelihoods, innovation, and Mission LiFE.
#upsc #news #headline #NitiAayog #UNDP #fasttrack #SDGs #Polity #cooperative #framework #sustainable #goals #Aayog #memorandum #districts #blocks #localisation #monitoring #collaboration #data #leadership #periodofyears #complex #challenges #livelihoods #innovation #mission #life #data #driven #patnership #demonstrating #nationwidwe #index #multidimensional